Abstract

We found previously that long-chain fatty acids could inhibit eukaryotic DNA polymerase activities in vitro [1, 2]. The purpose of the present study was to investigate the mode of this inhibition in greater detail. Among the C 18 to C 24 fatty acids examined, the strongest inhibitor was a C 24 fatty acid, nervonic acid (NA), and the weakest was a C 18 fatty acid, linoleic acid (LA). We analyzed the inhibitory effect of these two fatty acids and their modes of action. For DNA polymerase β (pol. β), NA acted by competing with both the substrate- and template-primer, but for DNA polymerase α (pol. α) or human immunodeficiency virus type 1 reverse transcriptase (HIV-1 reverse transcriptase or HIV-RT), NA acted non-competitively. NA-binding to pol. β could be stopped with a non-ionic detergent, but the binding to pol. α or HIV-RT could not. The inhibition mode of LA showed the same characteristics, except that the minimum inhibitory dose of the longer chain was much lower. We also tested the effects of NA and LA using pol. β and its proteolytic fragments, as described by Kumar et al. [3, 4]. Both of the fatty acids were found to bind to the 8 kDa DNA-binding domain fragment, and to suppress binding to the template-primer DNA. We found that 10 000 times more of either fatty acid was required for it to bind to the 31 kDa catalytic domain or inhibit the DNA polymerase activity. The possible modes of inhibition by these long-chain fatty acids are discussed, based on the present findings.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.